Takeda, BE join hands for dengue vaccine

Hyderabad: Biological E Limited (BE), a city-based vaccine maker, and Takeda, on Tuesday announced a strategic partnership to accelerate access to QDENGA (Dengue Tetravalent Vaccine (TAK-003) multi-dose vials (MDVs).These doses will be made available for procurement by governments in endemic countries by 2030 to support national immunisation programmes.

BE is likely to ramp up to a manufacturing capacity of up to 50 million doses a year, accelerating Takeda’s efforts to manufacture 100 million doses a year within the decade.